Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Leases: 2019-2025

Historic Current Leases for Sunshine Biopharma (SBFM) over the last 3 years, with Sep 2025 value amounting to $218,053.

  • Sunshine Biopharma's Current Leases rose 87.57% to $218,053 in Q3 2025 from the same period last year, while for Sep 2025 it was $218,053, marking a year-over-year increase of 87.57%. This contributed to the annual value of $207,756 for FY2024, which is 75.07% up from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Current Leases is $218,053, which was down 2.00% from $222,496 recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Current Leases peaked at $222,496 during Q2 2025, and registered a low of $114,452 during Q2 2024.
  • In the last 3 years, Sunshine Biopharma's Current Leases had a median value of $121,303 in 2023 and averaged $153,486.
  • Its Current Leases has fluctuated over the past 5 years, first decreased by 6.30% in 2024, then soared by 94.40% in 2025.
  • Sunshine Biopharma's Current Leases (Quarterly) stood at $123,026 in 2022, then dropped by 3.54% to $118,670 in 2023, then spiked by 75.07% to $207,756 in 2024, then soared by 87.57% to $218,053 in 2025.
  • Its Current Leases was $218,053 in Q3 2025, compared to $222,496 in Q2 2025 and $213,983 in Q1 2025.